Katerina Chatzidionysiou

18PUBLICATIONS
72CO-AUTHORS
PharmacogenomicsMolecular targetsRheumatology and arthritisBiomechanicsClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 15, 2025
Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA register.

Emma Wettersand, Daniela di Giuseppe, Johan Askling

|Dec 31, 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Eden Sebbag, Kim Lauper, Juan Molina-Collada

|Sep 23, 2024
Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study.

Anna Eberhard, Daniela Di Giuseppe, Johan Askling

|Dec 27, 2023
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden.

Hannah Bower, Thomas Frisell, Daniela di Giuseppe

|Mar 02, 2023
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study.

Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha

|Feb 23, 2023
Evaluation of an individually tailored smoking-cessation intervention for patients with rheumatoid arthritis in an outpatient clinic.

M-L Karlsson, K Hertzberg-Nyquist, S Saevarsdottir

Pageof 3

Frequent Collaborators

6 joint publications

Johan Askling

4 joint publications

Carl Turesson

3 joint publications

Daniel Aletaha

3 joint publications

Ulf Lindström